Keudell/Morrison Wealth Management
Source: SEC Form 13F · as of Mar 2026Keudell/Morrison Wealth Management holds 26 biotech & pharma companies tracked by BioSniper, totaling $28.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$28.8M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 4,957 | $4.6M |
| ABBVAbbVie Inc. | 20,016 | $4.4M |
| PMPhilip Morris International Inc | 18,704 | $3.1M |
| GILDGILEAD SCIENCES, INC. | 15,016 | $2.1M |
| JNJJOHNSON & JOHNSON | 7,324 | $1.8M |
| AMGNAMGEN INC | 4,900 | $1.7M |
| MRKMerck & Co., Inc. | 13,376 | $1.6M |
| ELVElevance Health Inc. | 5,039 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 20,394 | $1.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,844 | $770K |
| SNYSanofi | 14,103 | $679K |
| PFEPFIZER INC | 20,888 | $587K |
| KYMRKymera Therapeutics, Inc. | 6,990 | $582K |
| AZNASTRAZENECA PLC | 2,343 | $462K |
| NVONovo Nordisk A/S | 11,928 | $438K |
| REGNREGENERON PHARMACEUTICALS, INC. | 567 | $438K |
| DGXQuest Diagnostics Incorporated | 2,203 | $432K |
| ARGXARGENX SE | 506 | $370K |
| ABTABBOTT LABORATORIES | 3,469 | $356K |
| NVSNovartis AG | 2,058 | $314K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 5,671 | $313K |
| MCKMcKesson Corporation | 322 | $279K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 612 | $273K |
| JAZZJazz Pharmaceuticals plc | 1,359 | $257K |
| VKTXViking Therapeutics, Inc. | 6,650 | $216K |
| ALTAltimmune, Inc. | 18,500 | $57K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.